2026 NPPES data Dermatology Physician NPI 1548250855
Verify on CMS →

LORI FEDORONKO

Dermatology Physician in TROY, Michigan. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
817
Medicare Part D claims · 352 beneficiaries · Dermatology Physician avg: 729
Generic prescribing
91%
generic claims · 9% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
0/100
▼ 83 pts below national avg 83.1 · [object Object]
Industry payments
$99
1 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: LORI FEDORONKO is a Dermatology Physician ([object Object]) practicing in TROY, Michigan with a Medicare Part D prescribing footprint of 817 claims across 352 beneficiaries — 9% brand-name prescribing . Their CMS MIPS Final Score of 0/100 (national average: 83.1) reflects performance across Quality, Cost, Interoperability, and Improvement Activities . Industry payments of $99 across 1 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: LORI FEDORONKO reported a CMS MIPS final score of 0 out of 100, below the 83.1 national average, and filed 817 Medicare Part D claims in 2023. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

Board certification likely (heuristic — not verified)

LORI FEDORONKO practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

LORI FEDORONKO at a glance

Below national average

NPI registry status

Active

Issued 10/27/2005

NPI 1548250855

Primary specialty

Dermatology Physician

Mid-sized

14,610 US NPIs in this specialty

Medicare Part D claims

817 12% vs specialty avg

2023 prescription claims

Specialty avg: 729

MIPS final score

0/100 83.1% pts

Penalty band band

vs 83.1 national avg

Specialty distribution in Michigan

How Dermatology Physician compares to other specialties among Michigan providers

Michigan providers

Dermatology Physician share within Michigan

1. Dermatology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Dermatology Physician share within Michigan

Medicare quality performance — MIPS

LORI FEDORONKO's 2023 MIPS final score plotted against the Dermatology Physician national average

Below national average
MIPS Final Score
0/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Dermatology Physician) — 0/100 vs national avg 83.1

0%100%National avg83%0%
MIPS final score (Dermatology Physician) — 0/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

LORI FEDORONKO is a Dermatology Physician provider practicing in TROY, Michigan, according to the CMS National Plan and Provider Enumeration System (NPPES). NPI: 1548250855. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

LORI FEDORONKO appears in the CMS NPPES registry as a Dermatology Physician provider at 1350 KIRTS BLVD, TROY, MI, 48084, with a listed phone of (248) 362-0222. NPI 1548250855 was issued on 10/27/2005. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what FEDORONKO most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 817 prescription claims written by this provider, covering 352 Medicare beneficiaries and totaling roughly $178K in drug spend, split 9% brand-name and 91% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 0/100 for the 2023 performance year (Quality 0), compared with the national average of 83.1.

Dermatology Physician is a mid-sized specialty nationwide, with 14,610 enrolled providers across 53 states and an average of 729 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

1350 KIRTS BLVD
TROY, MI 48084

Provider Details

NPI 1548250855
Specialty Dermatology Physician
Gender Female
NPI Issued 10/27/2005

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

0
Final Score
Avg: 83.1
0
Quality

Reporting: Individual

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for LORI FEDORONKO. Source: openpaymentsdata.cms.gov.

Total received

$99

Largest payer

Janssen Biotech, Inc.

Most common payment type

Education

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Michigan MI-BOM 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~41K Michigan medical licensees in 2023 — they are NOT specific to LORI FEDORONKO. To verify LORI FEDORONKO's current license status, search the MI-BOM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

123
Total board actions, Michigan 2023
Across 120 cases
3.00
Actions per 1,000 licensees
Michigan statewide rate
probation
Most common action type
44 cases

MI-BOM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Michigan disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Generic-heavy

LORI FEDORONKO — brand share 9.0%
Specialty average (est.)

9% brand-name claims vs 91% generic, on 817 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

817
Total Claims
$178K
Total Drug Cost
352
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
866
Total Day Supply
22,162
Brand vs Generic
9% brand / 91% generic
Brand Drug Cost
$152K
Generic Drug Cost
$25K
Antibiotic Claims
65

Patient Demographics

Average Patient Age
75.4 years
Avg HCC Risk Score
1.09
Gender Split
61% female / 39% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Triamcinolone Acetonide
146
Ketoconazole
112
Betamethasone Diprop Augmented
Betamethasone/Propylene Glyc
88
Metronidazole
54
Doxycycline Hyclate
44
Fluocinolone Acetonide
39
Valacyclovir
Valacyclovir Hcl
28
Econazole Nitrate
20
Otezla
Apremilast
20
Clindamycin Phosphate
18

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Dermatology Physician Overview

How LORI FEDORONKO fits within the Dermatology Physician landscape nationally.

14,610
Dermatology Physician Providers in US
53
States with Dermatology Physician
729
Avg Claims per Provider

LORI FEDORONKO's 817 claims are above the specialty average of 729.

Nearby Dermatology Physician Providers in Michigan

Other clinicians with the same primary specialty enrolled in Michigan, drawn from the same CMS NPPES roster as FEDORONKO.

Compare Dermatology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is LORI FEDORONKO's specialty?
LORI FEDORONKO specializes in Dermatology Physician and practices in TROY, Michigan.
How much does LORI FEDORONKO prescribe under Medicare Part D?
In 2023, LORI FEDORONKO wrote 817 Medicare Part D claims totaling $178K in drug costs for 352 beneficiaries.
What is LORI FEDORONKO's Medicare quality score?
LORI FEDORONKO has a CMS MIPS Final Score of 0/100 (Quality: 0). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is LORI FEDORONKO located?
LORI FEDORONKO is located at 1350 KIRTS BLVD, TROY, MI, 48084. Phone: (248) 362-0222.
What is LORI FEDORONKO's NPI number?
LORI FEDORONKO's National Provider Identifier (NPI) is 1548250855, issued on 10/27/2005.
Does LORI FEDORONKO prescribe more brand-name or generic drugs?
LORI FEDORONKO's prescribing is 9% brand-name and 91% generic drugs by claim count, with $152K in brand drug costs.
How many Dermatology Physician providers are there in the US?
There are 14,610 Dermatology Physician providers across 53 states in the US. The average Dermatology Physician provider writes 729 Medicare Part D claims per year.
What drugs does LORI FEDORONKO prescribe most often?
Based on 2023 Medicare Part D data, LORI FEDORONKO's most frequently prescribed drugs include Triamcinolone Acetonide, Ketoconazole, Betamethasone Diprop Augmented. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does LORI FEDORONKO accept Medicare?
LORI FEDORONKO appears in CMS Medicare data with 817 Part D claims and 352 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify LORI FEDORONKO's credentials?
LORI FEDORONKO's NPI is 1548250855. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology